Concepedia

Tina Alano

TA

3

Publications

64

Citations

3

H-Index

2020

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Molecular Oncology (United States)

Tina Alano is an author at Memorial Sloan Kettering Cancer Center specializing in tumor biology, cancer therapeutics, and cancer research.

ORCID

Top concepts

Publications per year

2020–2024

3

Publications

3

Phase II trial of bicalutamide in combination with palbociclib for the treatment of androgen receptor (+) metastatic breast cancer.

Ayca Gucalp, Leigh Ann Boyle, Tina Alano et al. · Journal of Clinical Oncology · 2020 · 29 citations

, , +15

Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors

Andrew Lin, Vasilisa A. Rudneva, Allison L. Richards et al. · Acta Neuropathologica · 2024 · 25 citations · Full text

Mutant <i>PIK3CA</i> is a targetable driver alteration in histiocytic neoplasms

Benjamin H. Durham, Oshrat Hershkovitz‐Rokah, Omar Abdel‐Wahab et al. · Blood Advances · 2023 · 10 citations · Full text

Rows per page

1–3 of 3